This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2007 Jan;93(1):39-44.

doi: 10.1136/hrt.2006.099911. Epub 2006 Sep 4.

Antithrombotic treatment in atrial fibrillation

L Kalra¹, G Y H Lip; Guideline Development Group for the NICE clinical guideline for the management of atrial fibrillation

Affiliations

PMID: 16952971
PMCID: PMC1861321
DOI: 10.1136/hrt.2006.099911

Review

Antithrombotic treatment in atrial fibrillation

L Kalra et al. Heart. 2007 Jan.

. 2007 Jan;93(1):39-44.

doi: 10.1136/hrt.2006.099911. Epub 2006 Sep 4.

Authors

L Kalra¹, G Y H Lip; Guideline Development Group for the NICE clinical guideline for the management of atrial fibrillation

Affiliation

¹ Cardiovascular Division, King's College London School of Medicine, London, UK. lalit.kalra@kcl.ac.uk

PMID: 16952971
PMCID: PMC1861321
DOI: 10.1136/hrt.2006.099911

No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: None.

Figures

None

See this image and copyright information in PMC

Similar articles

Stroke risk assessment for atrial fibrillation: hospital-based stroke risk assessment and intervention program.
Jackson SL, Peterson GM. Jackson SL, et al. J Clin Pharm Ther. 2011 Feb;36(1):71-9. doi: 10.1111/j.1365-2710.2009.01156.x. J Clin Pharm Ther. 2011. PMID: 21198722
[Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].
Själander A, Wallentin L, Rosenqvist M, Svensson P. Själander A, et al. Lakartidningen. 2008 Sep 10-16;105(37):2478-80. Lakartidningen. 2008. PMID: 19006862 Swedish. No abstract available.
New anticoagulants for atrial fibrillation.
De Caterina R, Kristensen SD, Renda G. De Caterina R, et al. J Cardiovasc Med (Hagerstown). 2009 Jun;10(6):446-53. doi: 10.2459/JCM.0b013e3283249aee. J Cardiovasc Med (Hagerstown). 2009. PMID: 19365276 Review.
Atrial fibrillation: stroke prevention in older adults.
Quinn GR, Fang MC. Quinn GR, et al. Clin Geriatr Med. 2012 Nov;28(4):617-34. doi: 10.1016/j.cger.2012.08.003. Clin Geriatr Med. 2012. PMID: 23101573 Review.
Antithrombotic therapies for stroke prevention in atrial fibrillation.
Hart RG. Hart RG. Adv Neurol. 2003;92:249-56. Adv Neurol. 2003. PMID: 12760190 Review. No abstract available.

See all similar articles

Cited by

Antithrombotic medication for cardioembolic stroke prevention.
Font MÀ, Krupinski J, Arboix A. Font MÀ, et al. Stroke Res Treat. 2011;2011:607852. doi: 10.4061/2011/607852. Epub 2011 Jun 22. Stroke Res Treat. 2011. PMID: 21822469 Free PMC article.
Atrial Fibrillation and Hypertension: Mechanistic, Epidemiologic, and Treatment Parallels.
Ogunsua AA, Shaikh AY, Ahmed M, McManus DD. Ogunsua AA, et al. Methodist Debakey Cardiovasc J. 2015 Oct-Dec;11(4):228-34. doi: 10.14797/mdcj-11-4-228. Methodist Debakey Cardiovasc J. 2015. PMID: 27057292 Free PMC article. Review.
Clinical use of aspirin in treatment and prevention of cardiovascular disease.
Dai Y, Ge J. Dai Y, et al. Thrombosis. 2012;2012:245037. doi: 10.1155/2012/245037. Epub 2011 Nov 24. Thrombosis. 2012. PMID: 22195280 Free PMC article.
Analysis of antithrombotic therapy after cardioembolic stroke due to atrial fibrillation or flutter.
Peterson EJ, Reaves AB, Smith JL, Oliphant CS. Peterson EJ, et al. Hosp Pharm. 2013 Feb;48(2):127-33. doi: 10.1310/hpj4802-127. Hosp Pharm. 2013. PMID: 24421450 Free PMC article.
Stroke prevention in the high-risk atrial fibrillation patient: Medical management.
Broukhim M, Halperin JL. Broukhim M, et al. Curr Cardiol Rep. 2011 Feb;13(1):9-17. doi: 10.1007/s11886-010-0148-z. Curr Cardiol Rep. 2011. PMID: 20953740 Review.

See all "Cited by" articles

References

1. Fleming H A, Bailey S M. Mitral valve disease, systemic embolism and anticoagulants. Postgrad Med J 197147599–604. - PMC - PubMed
1. Salem D N, Stein P D, Al‐Ahmad A.et al Antithrombotic therapy in valvular heart disease—native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004126(Suppl)S457–S482. - PubMed
1. Szekely P. Systemic embolism and anticoagulant prophylaxis in rheumatic heart disease. BMJ 196453921209–1212. - PMC - PubMed
1. Wolf P A, Abbott R D, Kannel W B. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke 199122983–988. - PubMed
1. Petersen P, Madsen E B, Brun B.et al Silent cerebral infarction in chronic atrial fibrillation. Stroke 1987181098–1100. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information